BONESUPPORT Investor Relations Material
Latest events
Q1 2025
BONESUPPORT
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BONESUPPORT HOLDING
Access all reports
BONESUPPORT HOLDING, an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company's product, CERAMENT is a medical device that helps stimulate and accelerate the patient's own bone healing process. It is also involved in designing, developing, manufacturing, selling, marketing, and distributing of therapeutic products; and provision of research activities for new applications for drugs
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
BONEX
Country
🇸🇪 Sweden